Karin Briner

1 Patent

• US118133062023

  Cyclic Tetramer Compounds as Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Inhibitors for the Treatment of Metabolic Disorders

  Novartis AG

  0 cites